V. M. Salgaocar Medical Research Centre

Details
Medical Suppliers In Goa

Name :

V. M. Salgaocar Medical Research Centre

Address  :

V. M. Salgaocar Hospital
Off Airport Road,

Town  :

Chicalim

State  :

Goa

Country  :

INDIA

Post Code:

403711

Phone  :

91832 6691919

Fax  :

91832 2542622

Web URL  :

Available

Email  :

smrc@smrcgoa.org
Specialization
  • Anaesthesiology
  • Dentistry
  • Dermatology
  • ENT
  • Gastro-enterology
  • Internal Medicine
  • Obestetrician/Gynecologist
  • Ophthalmology
  • Orthopedics
  • Paediatrics
  • Plastic Surgery
  • Urology
Facilities

Total Number Of Beds : 120

Description
VMSalgaocar Medical Research Centre was established in 1978 at Chicalim Goa as part of our commitment to provide better health care in Goa The Centre now runs the ultramodern multispecialty tertiary care VM Salgaocar Hospital with 120 beds including 26 for critical care The Hospital offers comprehensive medical services from clinical investigations to surgery and postoperative care with stateoftheart equipment An Out Patient Department a DayCare Centre and an exclusive Centre for Health Checks make it unique It includes the VIVUS SMRC Heart Centre dedicated to complete cardiac care covering invasive noninvasive diagnostic and cardiac surgery

A team of highly qualified medical professionals paramedical staff and managerial support executives offer round the clock dedicated services All disciplines and departments regularly update their knowledge and skills in clinical and research studies to ensure international standards in healthcare
NEWS
Hand hygiene reduces healthcareacquired infections

New Delhi The World Health Organisation WHO Friday said the number of infections acquired during medical or surgical procedures can be brought down by 50 percent if good hand hygiene is followed May 5 is observed as World Hand Hygiene Day There is clear evidence that hundreds of millions of patients are infected every year worldwide by healthcar... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More